22 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
American Society of Transplantation Transplant Research Institute Grant Program
Since 1995, the American Society of Transplantation (AST) has invested millions of dollars to spur innovative research that has dramatically enhanced the field of organ transplantation. In an effort to benefit a broader number of investigators in more creative ways, the AST established the Transplant Research Institute (TRI) for the purposes of expanding the scope, reach, and effectiveness of the AST's research program. Among its many goals, the TRI seeks to elicit novel research topics and collaborative research opportunities from its partners in both industry and academia that are critical to advancing the science and practice of transplantation.
For 2014, the AST TRI considers applications in the following grant categories:
Faculty Development Grants
Basic Science Faculty Development Grant
Clinical Science Faculty Development Grant
Basic Science Fellowship Grant
Clinical Science Fellowship Grant
Applications for TRI grants must be completed by 11:59 PM Pacific Time on Monday, December 16, 2013. The submission site will automatically close after the deadline. No applications or supplementary documents will be accepted after the submission deadline.
The funding of any grant and total number of grants awarded by the TRI is dependent upon budgetary constraints in a given year. Grants may be funded for a one- or two-year period.
Letters of recommendation with original signatures on institutional letterhead must be uploaded to the online application.
Applicants for Faculty Development Grants and sponsors of Fellowship Grants must be members of the AST. If an applicant or sponsor is not a member, he/she must submit a completed membership application prior to the submission deadline. It is expected that membership will be active before the grant recipient is selected. 2014 AST membership dues must be paid by January 1, 2014. Apply for membership here.
Recipients of an AST TRI Grant will be recognized at the World Transplant Congress, July 26-31, 2014, in San Francisco. Recipients are expected to attend the WTC and must register for the congress. Registration to the WTC is NOT included with your grant.
No indirect costs are permitted.
Grant funding is not transferable from one recipient to another.
Research should begin on July 1, 2014.
DISCLAIMER: The AST will not assume responsibility for any clinical study funded by the TRI. Such proposals must be IRB-approved. Any responsibility will be assumed by the PI and the funded institution.
Quality in Endoscopic Research Award
Submission Deadline: January 31, 2014 at 5pm CST.
This award will fund studies to measure or improve quality of care (clinical or patient-oriented or physician behavior outcomes) and/or efficiency in gastrointestinal endoscopy, such as studies to improve the quality of screening colonoscopy. The research committee will consider feasibility/pilot/validation studies if there is an explicit justification for needing preliminary data in anticipation of a subsequent, more definitive, fundable study.
To foster research relating to measuring quality in gastrointestinal endoscopy both in the academic and private practice setting.
Candidate must be an ASGE member (ASGE membership at the time of application is a requirement for eligibility for grants and awards), be an MD (or have equivalent degree), and be currently practicing in a gastrointestinal endoscopy-related academic institution or private practice setting in North America. Candidates who are delinquent on prior ASGE research grant progress reports are not eligible for future ASGE funding. If the candidate is a trainee, there must be a letter from the Division Chief confirming the trainee's ongoing appointment at the institution for the duration of the grant, and their position title, and/or a contingency plan.
Grants may be requested for up to $75,000 in total funding, and spread over two years of study. Note: If the application is not selected for the Quality in Endoscopy Research Award, it will still be considered for an Endoscopic Research Award.
Requests for funding "seed" projects that will lead to further research, as well as larger requests for definitive clinical trials will be considered. In order to maximize the funds available for research, money for travel to meetings will not be provided, nor will funding be provided for indirect costs.
Grants are awarded based on the scientific merit of the proposal and assessment of the investigator's ability to complete the project (supportive environment, experience, training, availability of patients and other resources needed). The proposed research project must be approved by the ASGE Research Committee and should also be of such quality as to lead to presentation at Digestive Disease Week and subsequent full publication. One objective of these ASGE awards is the eventual submission of larger research funding requests, including federal funding, and proposals with such potential will be given priority.
Damon Runyon Clinical Investigator Award
The 2014 application deadline date for this award is Monday, February 17, 2014.
The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine.
The Clinical Investigator Award responds to three recognized realities:
• Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year.
• The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low.
• The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.
The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.
The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.
Definition of Clinical Research
For the purposes of this award, the Foundation’s definition of clinical research will follow the definition set out in “The NIH Director’s Panel on Clinical Research Report to The Advisory Committee to The NIH Director,” December, 1997.
a) Patient-oriented research: Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator directly interacts with human subjects. This area of research includes: patient-based studies of mechanisms of human disease, diagnostic and therapeutic interventions, clinical trials and development of new technologies for the detection, treatment and prevention of human cancers.
b) Epidemiologic and behavioral studies.
c) Outcomes research and health services research.
Excluded from this definition are in vitro studies that utilize human tissues but do not deal directly with patients. In other words, clinical or patient-oriented research is research in which it is necessary to know the identity of the patient(s) from whom the cells or tissues under study are derived.
Preference will be given to research that adheres to the “Handshake Rule,” meaning that the physician will conduct research studies that directly involve patients.
Pediatric Infectious Diseases Society Fellowship Award
Completed applications for the Pediatric Infectious Diseases Society Fellowship Award must be received by March 7, 2014 for the award cycle that begins on July 1, 2014.
Goals: The goal of the Fellowship Awards is to help increase the pool of highly trained pediatric infectious disease clinical scientists and to stimulate scholarly basic and clinical research in the following areas pertinent to pediatrics: public health/epidemiology, hospital epidemiology, clinical trials of antimicrobials, outcomes research, pharmacokinetics, pathophysiology, molecular pathogenesis, research related to vaccine development, and other topics of relevance to pediatric infectious diseases.
NOTE: The Society encourages applications for clinically applied/translational research.
Eligibility: Candidates must possess a MD or MD/PhD and be at least a first-year fellow in a Pediatric Infectious Diseases program in North America at the time of application. The award will be given for two subsequent years of training, during which time the applicant is expected to devote the major portion (at least 75% of time) of those years conducting the proposed research project under the direct supervision of a mentor who must be a PIDS member in good standing for at least one year.
Support: The annual stipend will be $45,000 and will be given for two years, subject to review at the end of the first year. In the case of awards given to a candidate in the final year of fellowship, only one year of the award will be given to the recipient. The stipend is intended to provide salary and benefits for the fellow. It is not intended to provide resources for a division's research program, nor to pay indirect costs of the institution.
Application and Selection Process: Application materials must be received by 5:00 pm EST on Friday, March 7, 2014. Electronic submission is strongly preferred.
American Gastroenterological Association-Boston Scientific Career Development Technology and Innovation Award
Eligibility: Young Investigators
Duration: Two years
Deadline: Jan. 31
Payment Date: July 1
This award provides $90,000 per year for two years (total $180,000) to young investigators working toward independent careers in gastroenterology, hepatology, or related areas focused on technology and innovation. The award can be used to acquire skills in novel/advanced biomedical technology (for example, but not limited to, endoscopic, nanotechnology, etc.) as it relates to a specific research plan, acquire skills in outcomes research as it relates to novel/advanced biomedical technology, acquire skills in educational techniques relevant to advanced biomedical technology, develop a unique and novel technology that has applications to clinical care, research and develop a new device that can be used to treat or diagnose a digestive disease, design and test a significant improvement to an existing technology, develop a new diagnostic, or develop a novel research method technology.
The overall objective of this career development award is to enable young investigators to develop independent and productive research careers in the field of biomedical technology by ensuring that a major proportion of their time is protected for research.
• Candidates for this award must hold an MD, PhD or equivalent degree (e.g. MB, ChB, MBBS, DO) and a full-time faculty position at a North American institution by July 1, 2014.
• AGA membership is required at the time of application submission. Please visit www.gastro.org/membership or call 301-654-2055, extension 651, for membership information.
• The award is intended to support young faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research. Candidates should be in the beginning years of their careers; therefore, established investigators are not appropriate candidates.
• MD applicants: No more than seven years shall have elapsed following the completion of clinical training (GI fellowship or its equivalent) and the start date of this award.
• PhD applicants: No more than seven years shall have elapsed following the awarding of your PhD and the start date of this award.
• Women and underrepresented minority applicants are strongly encouraged to apply; these applications in particular will receive the review committee’s full consideration.
• An appropriately documented parental leave of absence will not be counted toward the above noted seven year eligibility criteria. Exceptional circumstances may also be considered.
• All submissions must be relevant to diagnosing, treating or researching the functions or diseases of the digestive system.
• At the time of application submission, candidates may not hold or have held an NIH R01, R29, R21, K08, K23, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (such as the American Liver Foundation, Burroughs Wellcome Fund, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation, etc.). Candidates with an active K12 may apply.
• The intent of this award is to foster the scientific independence of junior investigators. It is understood that there may be some overlap with work funded by the mentor, but the goal of this grant is to enable the junior investigator to develop their own research program. It also must be clearly stated that the work submitted by the applicant is primarily that of the applicant, and any work or data from the senior mentor’s laboratory clearly defined.
• Resources allocated through this award are intended to support the career development of the applicant. Accordingly, requests for salary, fringe benefits or other support for the mentor are not allowed. Indirect costs are not allowed. Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation. Evidence for developing independence in research initiatives should be provided.
• Candidates are required to have a sponsor and preceptor for the award; however, one individual may serve in the capacity of both positions. A sponsor is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A preceptor will supervise the principal investigator’s research activities and will serve as a mentor.
• Annually, a one-page plain language progress report, a scientific progress report, a financial statement, a list of publications based on the research and a letter of certification from the division chief or department chair, must be submitted by the award recipient by July 30. Second year funding is contingent upon submission of this documentation. All publications, presentations and abstracts arising from work funded by this program must acknowledge support of the AGA -Boston Scientific Career Development Technology and Innovation Award.
• Post marketing studies of existing devices are not eligible.
There must be a strong commitment from the candidate’s institution to support the required protected time for research and adequate laboratory space and/or other supporting facilities. These commitments must be outlined in a letter from the candidate’s division chief or department chair. The letter must certify that the award is being used to provide protected time, in accord with the terms of the award. In addition, it is expected that the sponsor will outline specific plans for the future development of the candidate’s research career. The institution must commit to ensuring timely and accurate reporting of the awardee’s current and future research activities at the institution; this is to include an annual report of the funding status, grants submitted and pending, and all publications.
The recipient will be selected based on the following criteria: significance, investigator, innovation, approach, environment, relevance to AGA’s mission, and evidence of institutional commitment. The candidate should state clearly how the additional training will benefit his/her research career.
A selection committee comprised of members of the AGA Research Awards Panel and Center for GI Innovation and Technology will review the proposals and select the award recipients. Funding will commence July 2014.
The application deadline is Jan. 31. The completed application, letters of support or commitment and other documents, as applicable, must be combined into and submitted as one PDF document. The document must be titled by the applicant’s last name and first initial only. Hard copies are not accepted. Please email the application document. Direct all questions to the Research Awards Manager via telephone at 301-222-4012 or email.
Funding for this award is provided by Boston Scientific.
Society for Vascular Nursing Research Grant
All applicants for project/research support should submit requests on the Research Grant Application Form
for merit comparison of proposals. The applicant and the institution are required to affirm that satisfactory ethical precautions shall be taken with regard to projects involving human subjects as described in the guidelines. All applications shall be reviewed by the Vascular Nursing Research Grant Subcommittee of the Research Committee of the Society for Vascular Nursing.
The deadline for submitting an application for the 2014 SVN Research Grant has been extended until March 15, 2014.
The project coordinator/principal investigator (PC/PI) has scientific responsibilities for the conduct of the proposed clinical project/research and assumes responsibility for supervising such assistants as may be required. The PC/PI, along with the institution’s fiscal officer (when indicated), is also responsible for the expenditure and proper reporting of awarded funds.
The PC/PI must be a registered, professional nurse (RN).
Any PC/PI applicant without a Master of Science in Nursing (MSN) or a master’s degree in a related field must identify a nursing research consultant prepared at the master’s level or above who shall provide guidance throughout the project.
Top twenty vascular nursing research priorities
1. Strategies to increase public awareness of the signs and symptoms of vascular disease.
2. Strategies to increase public awareness of stroke warning signs.
3. Strategies to increase early detection and treatment of vascular disease.
4. Strategies to prevent amputation in high risk populations
5. Outcomes of patients cared for on a dedicated vascular unit vs. a medical-surgical unit.
6. Strategies to educate the public to help prevent the development of vascular disease.
7. Strategies to increase public awareness on the adverse effects of uncontrolled diabetes.
8. Strategies to manage chronic ischemic pain.
9. Strategies to reduce healthcare costs and length of stay while improving outcomes.
10. Nurse’s role in vascular ulcer prevention, identification, treatment, and education.
11. Strategies to increase diabetic patient compliance with diet, exercise, and glucose control.
12. Strategies to prevent wound and postoperative incision infections.
13. Outcomes of nurse-run clinics.
14. Effect of exercise on claudication symptoms.
15. Strategies to increase patient’s knowledge of venous ulcer prevention.
16. What is the patient’s understanding of discharge instructions after vascular surgery?
17. Nursing strategies to facilitate recovery after vascular surgery.
18. Factors that affect patient outcomes after major vascular procedures.
19. Prevention of readmissions in high risk patients.
20. Prevention of deep vein thrombosis in high risk patients.
Society for Vascular Surgery Clinical Research Seed Grants
Application Deadline: January 17, 2014
In recognition of the importance of clinical investigation in vascular disease, the SVS Foundation announces the Clinical Research Seed Grant program.
Purpose: It is vitally important, both to patients and to the specialty, that vascular surgeons play prominent roles in both industry and investigator-initiated clinical trials. The Clinical Research Seed Grant program has the following goals:
Encourage the interest and development of clinical investigators among the SVS membership, particularly junior members or those with limited prior experience as Principal Investigators
Provide direct support for pilot clinical projects that have potential to develop into larger studies fundable by industry or governmental sources
Scope: Clinical research, preferably patient-oriented (research conducted with human subjects or on material of human origin such as tissues, specimens and cognitive phenomena for which an investigator directly interacts with human subjects). Applications addressing one of the SVS Clinical Research Priorities are particularly encouraged. Small-scale clinical trials and ancillary studies in the setting of existing clinical trials (industry or NIH-supported) will be accepted. Relevant examples include:
Ancillary studies coupled to existing clinical trials. A letter of support from the primary trial sponsor is required.
Pilot clinical trials of any type
Studies on the natural history of vascular disease, pathophysiology, or mechanisms underlying success or failure of vascular interventions
Application of quality-of-life, functional status, and resource utilization measures to assess the impact of vascular interventions
Development and validation of clinical risk-prediction models or diagnostic tools
Studies addressing the nature of disparities in care and outcomes
Funding: $15,000 will be awarded for direct costs for a one-year period. Costs for laboratory assays, imaging studies (as appropriate), data collection, and statistical support are allowable. Principal investigator salary, institutional overhead expenses, major equipment and travel expenses are not allowed.
Eligibility: The principal investigator for the Clinical Research Seed Grant must be 1) an SVS Active Member within the first 10 years of practice or 2) a fellowship-trained, board-eligible, vascular surgeon within the first 10 years of practice with a full-time faculty position with an SVS Active Member serving as mentor. The principal investigator may submit only one application for the Clinical Research Seed Grant. Residents and fellows are not eligible.
Application Process: The deadline for applications is January 17, 2014. An electronic copy of the complete application must be must be submitted to SVSFoundation@vascularsociety.org on January 17, 2014. You will receive an email confirmation when your application has been received. Applications include the following:
Clinical Research Seed Grant Face Page
Clinical Research Proposal:
1 page - Specific aims
6 pages - Significance, innovation and research strategy (includes tables, graphs, figures, diagrams, charts)
Biosketch of Principal Investigator and any Co-Investigators
If applicable, based on the eligibility requirements, the application should include letter(s) of support from the SVS Member serving as mentor and/or any significant collaborator or consultant on the project.
Review Process: Applications will be reviewed by the SVS Clinical Research and Comparative Effectiveness Committee. Decisions regarding the grants are sent to applicants in March.
Reporting Requirements: At the completion of the study, or by the end of the one-year award period, the awardee must submit a report to the SVS Clinical Research and Comparative Effectiveness Committee.
Contact: Sarah Murphy, Society for Vascular Surgery, (312) 334-2305, Email: email@example.com
Society for Surgery of the Alimentary Tract Career Development Award for Clinical/Outcomes/Education Research
Deadline: February 7, 2014
This award is to assist in the development of young faculty members engaged in clinical, outcomes, and/or educational research in digestive diseases.
The supported research can be focused on clinical, outcomes, and educational research in digestive diseases. This includes but is not limited to clinical trial development, patient-centered outcomes research, health services research, comparative effectiveness research, cost-effectiveness research, and educational research.
The award is restricted to surgeons who have completed formal clinical and research training in general surgery and are within 5 years of their first faculty appointment in a department of surgery at a medical school accredited by the Liaison Committee on Medical Education in the United States or by the Committee for Accreditation of Canadian Medical Schools in Canada, or the equivalent national accrediting body for applicants from other countries.
At least 25% of the applicant’s time should be dedicated to the research and training outlined in the research plan. The Head of the Department and/or Division of General Surgery must ensure the applicant has the required protected time for research.
The SSAT award of $20,000 per year for two years is a career development award and is meant to support young investigators who have not been funded by a National Institutes of Health R01 Award or equivalent. In addition, if an investigator has received a similar type of career development award from another organization such as the American College of Surgeons, American Surgical Association, etc., he/she will be ineligible for the SSAT Career Development Research Award. It is the applicant’s responsibility to notify the SSAT of potential funding conflicts.
The award may be used to support clinical trial infrastructure (research assistants, data analysts, etc.), purchase of large administrative datasets necessary for conducting research, education/formal training in clinical research/biostatistics, and principal investigator salary support to ensure protected research time. No portion of the award is to be used for institutional indirect costs.
The recipient will present a progress report the SSAT leadership at the Annual Meeting during and immediately following the award period.
It is expected that the recipient submit abstracts arising from his/her Career Development Award-funded research to the SSAT Annual Meeting for presentation consideration, as well as manuscripts to the Journal of Gastrointestinal Surgery, the official journal of the SSAT, for publication consideration.
Call for Applications: Grant for Multiple Sclerosis Innovation
The deadline for grant applications is 28 February 2014.
The innovation grant will be awarded to support promising translational research projects by academic researchers to improve understanding of MS for the ultimate benefit of patients. Potential research topics that could be funded through the GMSI include MS pathogenesis, response to treatment and prediction of MS subtypes, identification of predictive or surrogate markers to allow better clinical decisions using currently available treatments as well as any potential new treatments, innovative patient support programmes, mobile health devices, or patient-reported outcomes. To be eligible to apply, applicants must have preliminary data to support their proposal.
A total grant of up to €1,000,000 will be awarded to one or more selected projects. The grant will build on the success of the Grant for Fertility Innovation (GFI), which has awarded grants that total up to €6,000,000 to translational research projects since 2010.
Applications are invited from around the world and will be reviewed by the Scientific Committee against the following criteria:
Relevance to clinical practice
For further information on the GMSI and to register your interest in applying for the GMSI 2014, please contact: firstname.lastname@example.org
Emergency Medicine Foundation Patient Centered Outcome Research Grant
Deadline for receipt of application - January 10, 2014
The Emergency Medicine Foundation endeavors to promote and to provide improved education and research in the field of emergency medicine in order to improve the availability and quality of emergency medical treatment.
The EMF Patient Centered Outcome Research Grant will award funds for research that describes the unique interaction between emergency clinician and patient in health policy or health services research topics. Applicants may apply for up to a total of $100,000 for a two year period.
Funding opportunities have emerged at the federal level focusing on the importance of patient centered care research. A unique aspect of this sphere of Patient Centered Outcome Research is that it aims to provide the best evidence to help patients and health care providers make more informed decisions. This grant application should be considered by anyone in emergency care research working toward optimal understanding of the prevention, treatment and care options available, and the science that supports optimal shared decision-making at the point of care.
For this one time grant opportunity, EMF encourages applications with a focus on optimal ways to measure and positively impact patient centered health outcomes in a meaningful way within the setting of emergency care.
Focus could include, but is not limited to, the following: optimizing patient and clinician decision-making with respect to test ordering, patient-clinician valuation of risks and benefits of treatment, patient decision-making regarding care goals in the context of chronic disease, and others. However, it is important to note that EMF welcomes all applications, including research that may not fit these examples. A key to this grant funding is that proposed work must involve in some way the participation of patients in the evaluation of health state outcomes relevant to emergency care.
The principal investigator is recognized as an accomplished investigator in the area of study proposed, and must have proven ability to pursue independent research as evidenced by original research publications in peer-reviewed journals or funding from extramural sources. The principal investigator must have a primary faculty appointment in Emergency Medicine. The principal investigator will make all arrangements for conduct of the proposed research projects, and assumes responsibility for conducting the research projects and supervising the work of all associate investigators.
The applicant is required to demonstrate that the project will be successfully completed at their institution. The applicant must demonstrate that access to a suitable caseload, patient population or database will be available for study during the funding period. Research must be approved by the institutional review board (IRB), or its equivalent, and a copy of the approval or pending approval sent with this application. IRB approval must be documented prior to dispensation of EMF funds.
The applicant must also submit a letter from the Chair/Director of Emergency Medicine stating that adequate funds and time will be available to the applicant to complete the proposed project.
EVALUATION OF APPLICATIONS
Each application will be reviewed by emergency medicine specialists who are actively involved in basic, clinical or health services research. Each application will be judged primarily on: (1) the significance of the project to emergency medicine, (2) the soundness of the research methodology, and (3) the likelihood the project will be completed. The final funding decision will be made by the Emergency Medicine Foundation Board of Trustees and all decisions are final.
TERMS OF THE AWARD
The Patient-Centered Outcomes Research Grant funds will be disbursed semi-annually over the two year cycle. Disbursement of payments will be contingent upon satisfactory progress reports.